Skip to main content

Table 2 Results of one-way ANOVA and Kruskal–Wallis tests in healthy control (HC) subjects only (a) across all 3 age groups, and (b) across the 2 age groups with predominantly premenopausal subjects (age ≤50 years)

From: Illness progression in chronic fatigue syndrome: a shifting immune baseline

(a) HC all age groups (b) HC groups age ≤50 years only
  p ANOVA p Kruskalwallis p ANOVA p Kruskalwallis
BMI 0.00 0.01 0.00 0.00
 IL-1α 0.23 0.04 0.12 0.12
 IL-1β 0.00 0.00 0.00 0.00
 IL-2 0.27 0.01 0.32 0.02
 IL-4 0.00 0.00 0.18 0.01
 IL-5 0.00 0.00 0.00 0.00
 IL-6 0.99 0.89 0.91 0.95
 IL-8 0.08 0.01 0.27 0.06
 IL-10 0.00 0.00 0.00 0.00
 IL-12p70 0.00 0.00 0.02 0.01
 IL-13 0.00 0.00 0.00 0.00
 IL-15 0.22 0.04 0.98 0.41
 IL-17 0.00 0.00 0.00 0.01
 IL-23 0.00 0.00 0.00 0.00
 IFNγ 0.02 0.02 0.00 0.01
 TNFα 0.89 0.33 0.82 0.17
 LTα 0.11 0.75 0.09 0.67
  1. p = > 0.10